Publication | Closed Access

Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China

Metastatic Cervical CancerCervical CancerPlacebo-controlled Phase 3MedicineClinical TrialsImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyGynecology OncologyPlatinum-based ChemotherapyHealth Sciences